Novartis's Exelon patch, applied once daily for the treatment of mild to moderate Alzheimer's disease, is not yet widely used by primary care physicians.
Ads by Google
Latinos and African Americans with Alzheimer's disease live longer than white people who have the disease.
There are more than 5 million Americans suffering from Alzheimer's disease, and an estimated 11 to 16 million will have Alzheimer's by the year 2050. Over 160,000 people in Georgia have been diagnosed with Alzheimer's, and 70 percent of them are cared for at home.
People with Alzheimer's disease who have high blood pressure, chest pains or an irregular heartbeat may lose their memories faster than others with Alzheimer's disease.
Consuming grapes may help prevent the onset of Alzheimer's disease.
Los Angeles Jewish Home is marking November's National Alzheimer's Disease Awareness Month by calling for increased understanding of an illness.
A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimer's disease.
Researchers have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer's disease.
Until recently, only one of the approximately 30,000 genes in the human genome has been linked to risk of late-onset Alzheimer's disease (AD).
About 2.4 million of those with dementia, or 9.7 percent of the population age 71 and older, were found to have Alzheimer's disease, the most common cause of dementia, according to the study.
Alzheimer's disease treatment with certain antihypertensive agents might be of benefit to individuals with, or at high risk of developing, Alzheimer's disease.
'The Book of Alzheimer's for African-American Churches' details information and facts about the disease from Texas prospective.
Memory Pharmaceuticals announced top-line data from the multi-center, randomized, double-blind, placebo-controlled Phase 2a study of MEM 1003, a neuronal L-type calcium channel modulator, in Alzheimer's disease.
An international team of scientists are developing the first blood test for Alzheimer's disease which experts hope will help doctors identify patients with the memory-robbing disease in its earliest stages.
The blood test for the prediction of Alzheimer's disease identifies changes in a handful of proteins in blood plasma that cells use to convey messages to one another.
Alzheimer's disease takes a long time to develop, which suggests that it may be possible to design drugs that work early in the disease process, to delay the start of symptoms. Over the past decade, researchers have been testing a number of such "disease-modifying" drugs that target the earliest biological changes in Alzheimer's, reports the October 2007 issue of the Harvard Mental Health Letter.
Individuals who are more conscientious - in other words, those with a tendency to be self - disciplined, scrupulous and purposeful - appear less likely to develop Alzheimer's disease.
A Mediterranean diet may help people with Alzheimer's disease live longer than patients who eat a more traditional Western diet.
The study followed 192 people with Alzheimer
New research now shows for the first time that, of all lifelong activities, only a high level of mental or cognitive activity protects against the devastating memory loss of Alzheimer's disease. High levels of social or physical activity are not enough.
This finding may provide a hint about how higher levels of cognitive reserve - which is believed to build by regularly engaging in mentally-stimulating activities such as taking classes, gardening and volunteering, provides protection against Alzheimer's disease or dementia by "exercising" the brain.
A new drug candidate dissolves plaques associated with Alzheimer's disease and other neurological diseases.
There is a Bridge, reveals different ways of communicating with those who have Alzheimer's disease.
A team of scientists led by professor Kiminobu Sugaya at the University of Central Florida may have found a new way to treat Alzheimer's disease.
Scientists in Scotland are one step further to finding a treatment for Alzheimer's disease, thanks to the development of a compound which reverses signs of the disease.
A drug initially used to treat mild to moderate Alzheimer's disease improved the memory and global function of people with severe Alzheimer's disease.
Millions of Americans swallow fish oil, hoping that omega-3 acids inside will protect their brains against memory loss and dementia. New study tests the effectiveness of fish oil on Alzheimer's disease.